Cadre (CDRE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Achieved record Q2 2024 financial performance with net sales of $144.3 million, up 19% year-over-year, and net income of $12.6 million, up 14%, driven by acquisitions and strong demand for armor and duty gear products.
Adjusted EBITDA for Q2 2024 was $28.3 million, up 24% year-over-year, with margin improving to 19.6%.
Continued focus on operational excellence, innovation, disciplined M&A, and automation to drive long-term growth and market leadership.
Declared eleventh consecutive quarterly dividend, with a quarterly cash dividend of $0.0875 per share in July 2024.
Benefiting from long-term industry tailwinds in public safety and nuclear safety sectors, with stable or increasing budgets.
Financial highlights
Q2 2024 net sales were $144.3 million, net income was $12.6 million ($0.31 per diluted share), and adjusted EBITDA was $28.3 million.
Gross profit margin for Q2 2024 was 40.6%–40.7%, impacted by acquisition-related costs and inflation.
Six-month net sales reached $282.2 million, up from $232.8 million year-over-year.
Orders backlog as of June 30, 2024, was $126.7 million to $151 million, reflecting acquisition contributions.
Cash and cash equivalents at June 30, 2024, totaled $105.9 million.
Outlook and guidance
Full-year 2024 net sales guidance is $571–$582 million, with adjusted EBITDA expected at $103–$109 million.
Q3 2024 results expected to be impacted by a July cyber incident, mainly deferring revenue to Q4; no significant changes to full-year guidance anticipated.
Capital expenditures for 2024 projected at $7–$9 million.
Management believes liquidity and cash flows are sufficient to meet requirements for at least the next 12 months.
Organic growth guidance for the back half of the year is about 5%, with a long-term target of 3–5%.
Latest events from Cadre
- Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation23 Mar 2026 - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 202511 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Stable demand, innovation, and operational focus drive growth and margin expansion.CDRE
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Cybersecurity incidents hit Q3, but record backlog and acquisitions support strong outlook.CDRE
Q3 202416 Jan 2026 - Strong market positions and strategic acquisitions drive growth in public safety and nuclear sectors.CDRE
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Strong Q3 2025 results and strategic acquisitions drive growth in safety and nuclear markets.CDRE
Investor presentation14 Jan 2026 - £75M acquisition doubles global nuclear scale and expands safety, robotics, and medicine reach.CDRE
M&A Announcement10 Jan 2026